Document is current
Any future updates will be listed below
-
Authors
Willis, Julian C. W. http://orcid.org/0000-0002-2655-2183
Silva-Pinheiro, Pedro http://orcid.org/0000-0002-0872-5749
Widdup, Lily
Minczuk, Michal http://orcid.org/0000-0001-8242-1420
Liu, David R. http://orcid.org/0000-0002-9943-7557
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (RM1HG009490)
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (R01EB027793, R01EB031172)
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (U01AI142756)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM118062)
Howard Hughes Medical Institute (Liu investigatorship)
- License Information
-
More Information
Article History
Received: 18 October 2022
Accepted: 7 November 2022
First Online: 23 November 2022
Competing interests
: The authors declare competing financial interests: J.C.W.W. and D.R.L. have filed patent applications on this work. D.R.L. is a consultant for Prime Medicine, Beam Therapeutics, Pairwise Plants, Chroma Medicine, and Nvelop Therapeutics, companies that use or deliver genome editing or genome engineering agents, and owns equity in these companies. M.M. is listed as an inventor on a patent related to this work (WO2007071962A1) and filed a patent application on this work (PCT/GB2019/050808). M.M. is a co-founder, shareholder and Scientific Advisory Board member of Pretzel Therapeutics. P.S.-P. is a consultant for Pretzel Therapeutics. L.W. declares no competing interests.
